Generic placeholder image

Combinatorial Chemistry & High Throughput Screening

Author(s): Saurabh K. Sinha, Satyendra K. Prasad, Md Ataul Islam, Sushil K. Chaudhary, Shashikant Singh and Anshul Shakya*

DOI: 10.2174/1386207323999200817103148

DownloadDownload PDF Flyer Cite As
Potential Leads from Liquorice Against SARS-CoV-2 Main Protease using Molecular Docking Simulation Studies

Page: [591 - 597] Pages: 7

  • * (Excluding Mailing and Handling)

Abstract

Aim and Objective: At present, the world is facing a global pandemic threat of SARSCoV- 2 or COVID-19 and to date, there are no clinically approved vaccines or antiviral drugs available for the treatment of coronavirus infections. Studies conducted in China recommended the use of liquorice (Glycyrrhiza species), an integral medicinal herb of traditional Chinese medicine, in the deactivation of COVID-19. Therefore, the present investigation was undertaken to identify the leads from the liquorice plant against COVID-19 using molecular docking simulation studies.

Materials and Methods: A set of reported bioactive compounds of liquorice were investigated for COVID-19 main protease (Mpro) inhibitory potential. The study was conducted on Autodock vina software using COVID-19 Mpro as a target protein having PDB ID: 6LU7.

Results: Out of the total 20 docked compounds, only six compounds showed the best affinity towards the protein target, which included glycyrrhizic acid, isoliquiritin apioside, glyasperin A, liquiritin, 1-methoxyphaseollidin and hedysarimcoumestan B. From the overall observation, glycyrrhizic acid followed by isoliquiritin apioside demonstrated the best affinity towards Mpro representing the binding energy of -8.6 and -7.9 Kcal/mol, respectively. Nevertheless, the other four compounds were also quite comparable with the later one.

Conclusion: From the present investigation, we conclude that the compounds having oxane ring and chromenone ring substituted with hydroxyl 3-methylbut-2-enyl group could be the best alternative for the development of new leads from liquorice plant against COVID-19.

Keywords: COVID-19, glycyrrhizic acid, isoliquiritin apioside, glyasperin, liquiritin, 1-Methoxyphaseollidin.

[1]
Zhu, N.; Zhang, D.; Wang, W.; Li, X.; Yang, B.; Song, J.; Zhao, X.; Huang, B.; Shi, W.; Lu, R.; Niu, P.; Zhan, F.; Ma, X.; Wang, D.; Xu, W.; Wu, G.; Gao, G.F.; Tan, W. China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med., 2020, 382(8), 727-733.
[http://dx.doi.org/10.1056/NEJMoa2001017] [PMID: 31978945]
[2]
World Health Organization. Coronavirus Disease (COVID-2019) Available from: https://covid19.who.int/2020
[3]
Prajapat, M.; Sarma, P.; Shekhar, N.; Avti, P.; Sinha, S.; Kaur, H.; Kumar, S.; Bhattacharyya, A.; Kumar, H.; Bansal, S.; Medhi, B. Drug targets for corona virus: A systematic review. Indian J. Pharmacol., 2020, 52(1), 56-65.
[http://dx.doi.org/10.4103/ijp.IJP_115_20] [PMID: 32201449]
[4]
Robson, B. Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus. Comput. Biol. Med., 2020, 119103670
[http://dx.doi.org/10.1016/j.compbiomed.2020.103670] [PMID: 32209231]
[5]
Jin, Z.; Du, X.; Xu, Y.; Deng, Y.; Liu, M.; Zhao, Y.; Zhang, B.; Li, X.; Zhang, L.; Peng, C.; Duan, Y.; Yu, J.; Wang, L.; Yang, K.; Liu, F.; Jiang, R.; Yang, X.; You, T.; Liu, X.; Yang, X.; Bai, F.; Liu, H.; Liu, X.; Guddat, L.W.; Xu, W.; Xiao, G.; Qin, C.; Shi, Z.; Jiang, H.; Rao, Z.; Yang, H. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 2020, 582(7811), 289-293.
[http://dx.doi.org/10.1038/s41586-020-2223-y] [PMID: 32272481]
[6]
Kim, D.W.; Seo, K.H.; Curtis-Long, M.J.; Oh, K.Y.; Oh, J.W.; Cho, J.K.; Lee, K.H.; Park, K.H. Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia. J. Enzyme Inhib. Med. Chem., 2014, 29(1), 59-63.
[http://dx.doi.org/10.3109/14756366.2012.753591] [PMID: 23323951]
[7]
Tahir Ul Qamar, M.; Maryam, A.; Muneer, I.; Xing, F.; Ashfaq, U.A.; Khan, F.A.; Anwar, F.; Geesi, M.H.; Khalid, R.R.; Rauf, S.A.; Siddiqi, A.R. Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus. Sci. Rep., 2019, 9(1), 1433.
[http://dx.doi.org/10.1038/s41598-018-38450-1] [PMID: 30723263]
[8]
Gupta, M.K.; Vemula, S.; Donde, R.; Gouda, G.; Behera, L.; Vadde, R. In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel. J. Biomol. Struct. Dyn., 2020, 1-11.
[http://dx.doi.org/10.1080/07391102.2020.1751300] [PMID: 32238078]
[9]
Zhang, D.H.; Wu, K.L.; Zhang, X.; Deng, S.Q.; Peng, B. In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus. J. Integr. Med., 2020, 18(2), 152-158.
[http://dx.doi.org/10.1016/j.joim.2020.02.005] [PMID: 32113846]
[10]
Prajapati, S.M.; Patel, B.R. A comparative clinical study of Jethimala (Taverniera nummularia Baker.) and Yashtimadhu (Glycyrrhiza glabra Linn.) in the management of Amlapitta. Ayu, 2015, 36(2), 157-162.
[http://dx.doi.org/10.4103/0974-8520.175551] [PMID: 27011716]
[11]
Jiang, M.; Zhao, S.; Yang, S.; Lin, X.; He, X.; Wei, X.; Song, Q.; Li, R.; Fu, C.; Zhang, J.; Zhang, Z. An “essential herbal medicine”-licorice: A review of phytochemicals and its effects in combination preparations. J. Ethnopharmacol., 2020, 249112439
[http://dx.doi.org/10.1016/j.jep.2019.112439] [PMID: 31811935]
[12]
Wang, X.; Zhang, H.; Chen, L.; Shan, L.; Fan, G.; Gao, X. Liquorice, a unique “guide drug” of traditional Chinese medicine: a review of its role in drug interactions. J. Ethnopharmacol., 2013, 150(3), 781-790.
[http://dx.doi.org/10.1016/j.jep.2013.09.055] [PMID: 24201019]
[13]
Liu, Y.; Hong, Z.; Qian, J.; Wang, Y.; Wang, S. Protective effect of Jie-Geng-Tang against Staphylococcus aureus induced acute lung injury in mice and discovery of its effective constituents. J. Ethnopharmacol., 2019, 243112076
[http://dx.doi.org/10.1016/j.jep.2019.112076] [PMID: 31295516]
[14]
Yang, R.; Yuan, B.C.; Ma, Y.S.; Zhou, S.; Liu, Y. The anti-inflammatory activity of licorice, a widely used Chinese herb. Pharm. Biol., 2017, 55(1), 5-18.
[http://dx.doi.org/10.1080/13880209.2016.1225775] [PMID: 27650551]
[15]
Bode, A.M.; Dong, Z. Chemopreventive effects of licorice and its components. Curr. Pharmacol. Rep., 2015, 1(1), 60-71.
[http://dx.doi.org/10.1007/s40495-014-0015-5] [PMID: 32226725]
[16]
Kim, A.; Ma, J.Y. Isoliquiritin apioside suppresses in vitro invasiveness and angiogenesis of cancer cells and endothelial cells. Front. Pharmacol., 2018, 9, 1455.
[http://dx.doi.org/10.3389/fphar.2018.01455] [PMID: 30618749]
[17]
Fukuchi, K.; Okudaira, N.; Adachi, K.; Odai-Ide, R.; Watanabe, S.; Ohno, H.; Yamamoto, M.; Kanamoto, T.; Terakubo, S.; Nakashima, H.; Uesawa, Y.; Kagaya, H.; Sakagami, H. Antiviral and antitumor activity of licorice root extracts. In Vivo, 2016, 30(6), 777-785.
[http://dx.doi.org/10.21873/invivo.10994] [PMID: 27815461]
[18]
Wang, L.; Yang, R.; Yuan, B.; Liu, Y.; Liu, C. The antiviral and antimicrobial activities of licorice, a widely-used Chinese herb. Acta Pharm. Sin. B, 2015, 5(4), 310-315.
[http://dx.doi.org/10.1016/j.apsb.2015.05.005] [PMID: 26579460]
[19]
Ayeka, P.A.; Bian, Y.; Githaiga, P.M.; Zhao, Y. The immunomodulatory activities of licorice polysaccharides (Glycyrrhiza uralensis Fisch.) in CT 26 tumor-bearing mice. BMC Complement. Altern. Med., 2017, 17(1), 536.
[http://dx.doi.org/10.1186/s12906-017-2030-7] [PMID: 29246138]
[20]
Feng Yeh, C.; Wang, K.C.; Chiang, L.C.; Shieh, D.E.; Yen, M.H.; San Chang, J. Water extract of licorice had anti-viral activity against human respiratory syncytial virus in human respiratory tract cell lines. J. Ethnopharmacol., 2013, 148(2), 466-473.
[http://dx.doi.org/10.1016/j.jep.2013.04.040] [PMID: 23643542]
[21]
Cinatl, J.; Morgenstern, B.; Bauer, G.; Chandra, P.; Rabenau, H.; Doerr, H.W. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet, 2003, 361(9374), 2045-2046.
[http://dx.doi.org/10.1016/S0140-6736(03)13615-X] [PMID: 12814717]
[22]
Shahid, A.; Chowdhury, M.A.; Kashem, M.A. Scope of natural plant extract to deactivate COVID 19. Biopolymers, 2020.
[http://dx.doi.org/10.21203/rs.3.rs-19240/v1]
[23]
Chen, Y.; Guo, Y.; Pan, Y.; Zhao, Z.J. Structure analysis of the receptor binding of 2019-nCoV. Biochem. Biophys. Res. Commun., 2020, 525, 135-140.
[24]
Kim, S.; Thiessen, P.A.; Bolton, E.E.; Chen, J.; Fu, G.; Gindulyte, A.; Han, L.; He, J.; He, S.; Shoemaker, B.A.; Wang, J.; Yu, B.; Zhang, J.; Bryant, S.H. PubChem Substance and Compound databases. Nucleic Acids Res., 2016, 44(D1), D1202-D1213.
[http://dx.doi.org/10.1093/nar/gkv951] [PMID: 26400175]
[25]
Trott, O.; Olson, A.J. AutoDock Vina: iMproving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem., 2010, 31(2), 455-461.
[PMID: 19499576]
[26]
Liu, X.; Zhang, B.; Jin, Z.; Yang, H.; Rao, Z. The crystal structure of COVID-19 main protease in complex with an inhibitor N3; PDB, 2020.
[27]
Morris, G.M.; Huey, R.; Lindstrom, W.; Sanner, M.F.; Belew, R.K.; Goodsell, D.S.; Olson, A.J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem., 2009, 30(16), 2785-2791.
[http://dx.doi.org/10.1002/jcc.21256] [PMID: 19399780]
[28]
Salentin, S.; Schreiber, S.; Haupt, V.J.; Adasme, M.F.; Schroeder, M. PLIP: fully automated protein-ligand interaction profiler. Nucleic Acids Res., 2015, 43(W1)W443-7
[http://dx.doi.org/10.1093/nar/gkv315] [PMID: 25873628]
[29]
Ortega, J.T.; Serrano, M.L.; Pujol, F.H.; Rangel, H.R. Unrevealing sequence and structural features of novel coronavirus using in silico approaches: The main protease as molecular target. EXCLI J., 2020, 19, 400-409.
[PMID: 32210741]
[30]
Curreli, F.; Friedman-Kien, A.E.; Flore, O. Glycyrrhizic acid alters Kaposi sarcoma-associated herpesvirus latency, triggering p53-mediated apoptosis in transformed B lymphocytes. J. Clin. Invest., 2005, 115(3), 642-652.
[http://dx.doi.org/10.1172/JCI200523334] [PMID: 15765147]
[31]
De Clercq, E. Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med. Res. Rev., 2000, 20(5), 323-349.
[http://dx.doi.org/10.1002/1098-1128(200009)20:5<323:AID-MED1>3.0.CO;2-A] [PMID: 10934347]
[32]
Grienke, U.; Schmidtke, M.; Kirchmair, J.; Pfarr, K.; Wutzler, P.; Dürrwald, R.; Wolber, G.; Liedl, K.R.; Stuppner, H.; Rollinger, J.M. Antiviral potential and molecular insight into neuraminidase inhibiting diarylheptanoids from Alpinia katsumadai. J. Med. Chem., 2010, 53(2), 778-786.
[http://dx.doi.org/10.1021/jm901440f] [PMID: 20014777]
[33]
Fukai, T.; Marumo, A.; Kaitou, K.; Kanda, T.; Terada, S.; Nomura, T. Anti-Helicobacter pylori flavonoids from licorice extract. Life Sci., 2002, 71(12), 1449-1463.
[http://dx.doi.org/10.1016/S0024-3205(02)01864-7] [PMID: 12127165]
[34]
Park, J.H.; Lee, S.U.; Kim, S.H.; Shin, S.Y.; Lee, J.Y.; Shin, C.G.; Yoo, K.H.; Lee, Y.S. Chromone and chromanone derivatives as strand transfer inhibitors of HIV-1 integrase. Arch. Pharm. Res., 2008, 31(1), 1-5.
[http://dx.doi.org/10.1007/s12272-008-1111-z] [PMID: 18277599]
[35]
Baker, D. The University of Tennessee Research Corporation, Knoxville, Tenn. Pyran-Chromenone Compounds, their Synthesis and Anti-HIV Activity United States Patent 5,843,990, 1998.